Early research (Phase 1)Study completedNCT00623831
What this trial is testing
Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Who this might be right for
MelanomaSarcomaGastrointestinal Stromal Tumor (GIST)+6 more
Ludwig Institute for Cancer Research 17